Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform

Volume: 385, Issue: 22, Pages: 2017 - 2019
Published: Nov 25, 2021
Abstract
Interview with Dr. James Robinson on the aducanumab experience and the structural factors responsible for high drug prices in the United States. (10:44)Download Aducanumab’s price can inform the drug-pricing policy debate because it responds to key features of the market environment for physician-administered drugs: Medicare’s reimbursement formula, payment to physicians for infused drugs, and cost-sharing...
Paper Details
Title
Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform
Published Date
Nov 25, 2021
Volume
385
Issue
22
Pages
2017 - 2019
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.